-
Thermally-stable TB vaccine developed using new technique
europeanpharmaceuticalreview
August 09, 2019
A new process developed by the University of Bath protects a TB antigen and a novel vaccine adjuvant from heat damage.
-
GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute
drugs
August 08, 2019
GSK and the Sabin Vaccine Institute (Sabin) today announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire...
-
Philippines may re-introduce controversial dengue vaccine
europeanpharmaceuticalreview
August 08, 2019
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
-
Major step towards Candida auris vaccine developed
europeanpharmaceuticalreview
August 08, 2019
Researchers have detailed recent breakthrough experiments that successfully immunised mice against the Candida auris infection.
-
GSK Grants Ebola Vaccine License to Sabin Vaccine Institute
contractpharma
August 07, 2019
Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines.
-
Dual Therapy Might Be Advance Against Genital Herpes, Animal Study Suggests
drugs
August 02, 2019
It's only been tried so far in guinea pigs, but researchers say a combination of a vaccine and a medicated cream could greatly lower recurrence of genital herpes.
-
Merck to Build $650M Biomanufacturing Plant in NC
contractpharma
July 30, 2019
New 225,000 square foot facility to produce active ingredient for the Gardasil 9 vaccine.
-
Targeted Interventions Raise HPV Vaccine Acceptance in Women
drugs
July 26, 2019
Among young women, targeted educational interventions, particularly educational videos...
-
Yisheng Biopharma receives approval from China NMPA for rabies vaccine production facility
biospectrumasia
July 23, 2019
The vaccine has demonstrated effective protection, contributing to the fight against rabies infection.
-
China set to begin Phase II HIV vaccine trials
europeanpharmaceuticalreview
July 23, 2019
A vaccine containing the DNA of HIV is poised to enter a Phase II trial, making it the first vaccine of its kind to do so.